Effects of Helicobacter pylori eradication therapy on the healing process of peptic ulcers
Imaizumi, H.; Koizumi, W.; Nakai, H.; Tanabe, S.; Ohida, M.; Saigenji, K.
Nihon Rinsho. Japanese Journal of Clinical Medicine 57(1): 167-172
1999
ISSN/ISBN: 0047-1852 PMID: 10036957 Document Number: 505933
The advent of H2-receptor antagonists (H2RA) and proton pump inhibitors (PPI) has particularly revolutionized the treatment of peptic ulcer disease. Most cases can now be successfully controlled by medical treatment with H2RA and PPI, but a high rate of ulcer recurrence remains an important problem. The quality of ulcer healing (QOUH) has therefore received increasing attention, and various investigators have attempted to define the conditions required for nonrecurrence. Ulcer scars with a good QOUH are considered to have a very low risk of recurrence. Recent studies have confirmed that recurrence of peptic ulcer can be suppressed markedly by eradication of Helicobacter pylori (H. p). Moreover, various types of endoscopic examinations (conventional observation, dye-contrast endoscopy, magnifying endoscopy, endoscopic ultrasonography, pharmacoendoscopy) have confirmed that the QOUH after eradication of H. p is better than that after conventional anti-ulcer therapy. H. p eradication therapy may become treatment of first choice for peptic ulcers.